Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program

AIM: Anticoagulants (AC) and anti-platelet (AP) agents are widely administered to patients with hematological malignancies (HM). However, HM patients may be at high risk of bleeding and hemorrhagic complications, because of different form of coagulopathies and several degrees of thrombocytopenia. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tendas, Andrea, Cupelli, Luca, Scaramucci, Laura, Palombi, Massimiliano, Trawinska, Malgorzata Monika, Giovannini, Marco, Brunetti, Gregorio Antonio, Cartoni, Claudio, Bondanini, Francesco, de Fabritiis, Paolo, Niscola, Pasquale
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098544/
https://www.ncbi.nlm.nih.gov/pubmed/21633622
http://dx.doi.org/10.4103/0973-1075.78450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098544/
https://www.ncbi.nlm.nih.gov/pubmed/21633622
http://dx.doi.org/10.4103/0973-1075.78450

Ejemplares similares